ProQR Therapeutics N.V.

NASDAQ: PRQR
Share price (1/8/25): $2.62
Market cap (1/8/25): $213 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/23 FY 2023

ended 12/31/22 FY 2022

ended 12/31/21 FY 2021

ended 12/31/20 FY 2020

ended 12/31/19 FY 2019

Prospectuses and Registrations Filter

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Shelf registration

Prospectus supplement for primary offering

Ownership Filter

Van Herk Investments B.V.

Van Herk Investments B.V.

Van Herk Investments B.V.

Rtw Investments, LP

Stichting Aescap Life Sciences

News Filter

Incorporation by Reference

Investor Presentation

Announces $8.1 Million in New Funding From Rett Syndrome Research Trust to Expand RNA Editing Collaboration

Appoints Peter A. Beal, PhD, as Chief ADAR Scientist

To Host Virtual Analyst and Investor Event on December 11, 2024

Proxies

No filings in this category.

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness

Correspondence with the SEC